The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II

This publication has 29 references indexed in Scilit:

• A fluorescent complex between ethidium bromide and nucleic acids: Physical—Chemical characterization
  Published by Elsevier ,2004
• The effect of topoisomerase inhibitors on the expression of differentiation markers and cell cycle progression in human K-562 leukemia cells
  Experimental Cell Research, 1992
• Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions
  Biochemistry, 1991
• Topoisomerase Inhibitors Have Potent Differentiation‐inducing Activity for Human and Mouse Myeloid Leukemia Cells
  Japanese Journal of Cancer Research, 1991
• Induction of differentiation of human and mouse myeloid leukemia cells by camptothecin
  Biochemical and Biophysical Research Communications, 1990
• Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage
  Biochemistry, 1985
• DNA topoisomerase II is required at the time of mitosis in yeast
  Cell, 1985
• Interaction of the antileukemic alkaloid, 2-hydroxy-3,8,9-trimethoxy-5-methylbenzo[c]phenanthridine (fagaronine), with nucleic acids
  Chemico-Biological Interactions, 1983
• Inhibition of reverse transcriptase activity of RNA-tumor viruses by fagaronine
  Biochemical and Biophysical Research Communications, 1975
• The change of the torsion of the DNA helix caused by intercalation: II — Measurement of the relative change of torsion induced by various intercalating drugs
  Biochimie, 1971